Phase 2, Open-label Study of PRAX-944 to Assess the Safety, and Efficacy of Escalating Multiple Doses in Adults with Refractory Absence Seizures

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Kwan, Patrick (Chief Investigator (CI))
  • Germaine, Jack (Associate Investigator (AI))
  • Smith, Rafael, (Associate Investigator (AI))
  • Casillas-Espinosa, Pablo (Associate Investigator (AI))
  • Reddy, Kiran (Partner Investigator (PI))
  • Piccenna, Loretta, (Project Manager)

Project: Research

Project Description

Funding awarded to Alfred Health, Amount awarded - $110,000
Effective start/end date18/02/1918/02/20